Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dihydroergotoxin mesylate manufacturers

7 products found

Filters

7 products found

dihydroergotoxin mesylate + aesculin + rutoside

Tablets, film coated 0.58 mg + 1.5 mg + 30 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17357
It has been around for nearly 70 years in the pharmaceutical market. Their products are of great quality. The items are of the greatest quality and meet all quality requirements, both domestically and internationally. They have a portfolio of around 30 different items. These include prescription and over-the-counter medications, as well as dietary supplements.

Manufacturer usually replies in 31 days

dihydroergotoxin mesylate

Oral solution 2 mg / ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17357
It has been around for nearly 70 years in the pharmaceutical market. Their products are of great quality. The items are of the greatest quality and meet all quality requirements, both domestically and internationally. They have a portfolio of around 30 different items. These include prescription and over-the-counter medications, as well as dietary supplements.

Manufacturer usually replies in 31 days

dihydroergotoxin mesylate

Capsules, modified release (MR) 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29065

Manufacturer usually replies in 5 days

dihydroergotoxin mesylate

Tablets 1.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20598
The company has a PIC/S GMP-certified pharmaceutical factory that has been approved by the TFDA. In recent years, with the rapid development of science and technology, the mutual penetration and promotion of various disciplines have greatly promoted the development of pharmaceuticals. New methods, new technologies, new equipment, new ingredients and new ingredients in modern drug manufacturing continue to emerge. The basic research has been deepened, applied research has been more perfect, and the development of pharmaceutical dosage forms has entered the era of new drug release systems from traditional dosage forms such as tablets, capsules, and injections. New products of various controlled and sustained-release dosage forms are on the market, and the research on targeted drug delivery preparations and pulse-controlled automatic drug delivery systems is developing rapidly.

Manufacturer usually replies in 18 days

dihydroergotoxin mesylate

Tablets 1.5mg, 4.5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Available for
Distribution only
Manufacturer #16240
It is a laboratory that produces several product lines, such as allergy, cardiology, clinic, dermatology, gastroenterology, geriatrics, neurology, pediatrics, psychiatry, and urology, among others.

Manufacturer usually replies in 6 days

citicoline + dihydroergotoxin mesylate

Tablets, film coated 100 mg + 4.5 mg, 250 mg + 4.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

paracetamol + caffeine + dihydroergotoxin mesylate

Tablets, film coated 450 mg + 40 mg + 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Chile
GMP approvals
WHO, INVIMA
Manufacturer #18571
The company produces and markets ophthalmologic products exclusively but expanded rapidly to other specialties, trying to obtain the position of one of the leaders within the international pharmaceutical industry. The company aspires to have the values of respect, loyalty, integrity, and responsibility, amongst others, prevail in all of its relationships with workers, authorities, competitors, clients, and the community at large.

Manufacturer usually replies in 5 days